Sample accession	Sample description	Run:Assembly accession	Pipeline version	Analysis accession	sample	Sampling date	patient ID	Age	Visit	Nugent score	Nugent score category	Amsel criteria fulfilled	pH	biofilm state	BV state*	biofilm	recurrence	S (16S)**	H' (16S)**	Metronidazole reaction
ERS1796479	04_001-1	ERR2014354	3	MGYA00132178	04_001_a	14-04-04	04-001	20	1	8	7 to 10	4	4.7	positive	positive	53.7	BV1	14	2.1841	positive
ERS1796480	04_001-2	ERR2014355	3	MGYA00132168	04_001_b	14-04-22	04-001	20	2	0	0 to 3	0	4.4	negative	negative	0		3	0.0555	positive
ERS1796481	04_001-3	ERR2014356	3	MGYA00132152	04_001_c	14-04-29	04-001	20	3	0	0 to 3	0	4	negative	negative	0		9	0.1483	na
ERS1796482	04_001-4	ERR2014357	3	MGYA00132155	04_001_d	14-05-13	04-001	20	4	0	0 to 3	0	4.4	negative	negative	0		3	0.0786	na
ERS1796483	04_001-5	ERR2014358	3	MGYA00132170	04_001_e	14-08-19	04-001	20	5	no Nugent Score	na	4	5	positive	positive	32.69	BV2	13	2.3384	na
ERS1796484	05_001-1	ERR2014359	3	MGYA00132177	05_001_a	14-04-10	05-001	29	1	8	7 to 10	4	5	positive	positive	55.56	no	12	2.1017	negative
ERS1796485	05_001-2	ERR2014360	3	MGYA00132162	05_001_b	14-04-28	05-001	29	2	8	7 to 10	0	4.5	positive	positive	27.27		9	1.4422	negative
ERS1796486	05_012-1	ERR2014361	3	MGYA00132167	05_012_a	14-10-23	05-012	24	1	10	7 to 10	4	5	positive	positive	21.57	no	13	2.0645	positive
ERS1796487	05_012-2	ERR2014362	3	MGYA00132161	05_012_b	14-11-13	05-012	24	2	0	0 to 3	0	4.5	negative	negative	0		7	0.5441	positive
ERS1796488	06_001-1	ERR2014363	3	MGYA00132175	06_001_a	14-04-01	06-001	26	1	9	7 to 10	4	6	positive	positive	92.31	no	13	2.0199	negative
ERS1796489	06_001-2	ERR2014364	3	MGYA00132169	06_001_b	14-04-17	06-001	26	2	10	7 to 10	0	4	positive	positive	69.64		13	1.9835	negative
ERS1796490	06_004-1	ERR2014365	3	MGYA00132182	06_004_a	14-06-02	06-004	31	1	10	7 to 10	4	5.5	positive	positive	43.14	BV1	14	1.921	positive
ERS1796491	06_004-2	ERR2014366	3	MGYA00132158	06_004_b	14-06-11	06-004	31	2	0	0 to 3	0	4	negative	negative	0		10	0.5461	positive
ERS1796492	06_004-3	ERR2014367	3	MGYA00132185	06_004_c	14-06-18	06-004	31	3	8	7 to 10	2	5	positive	positive	76.47	BV2	12	1.9678	na
ERS1796493	06_004-4	ERR2014368	3	MGYA00132147	06_004_d	14-07-03	06-004	31	4	0	0 to 3	0	4.5	negative	negative	0		9	0.8351	na
ERS1796494	06_004-5	ERR2014369	3	MGYA00132184	06_004_e	14-09-26	06-004	31	5	no Nugent Score	na	0	4.5	negative	negative	16		11	0.5334	na
ERS1796495	06_006-1	ERR2014370	3	MGYA00132171	06_006_a	14-07-10	06-006	32	1	10	7 to 10	4	6	positive	positive	38.89	no	na	na	negative
ERS1796496	06_006-2	ERR2014371	3	MGYA00132176	06_006_b	14-07-31	06-006	32	2	10	7 to 10	3	5.5	positive	positive	84.31		na	na	negative
ERS1796497	06_010-1	ERR2014372	3	MGYA00132183	06_010_a	15-03-18	06-010	27	1	8	7 to 10	4	5	positive	positive	100	no	11	1.7452	positive
ERS1796498	06_010-2	ERR2014373	3	MGYA00132159	06_010_b	15-04-16	06-010	27	2	0	0 to 3	0	4	negative	negative	0		6	0.7622	positive
ERS1796499	07_001-1	ERR2014374	3	MGYA00132180	07_001_a	14-07-03	07-001	22	1	8	7 to 10	4	7	positive	positive	54.55	no	12	2.1876	negative
ERS1796500	07_001-2	ERR2014375	3	MGYA00132154	07_001_b	14-07-24	07-001	22	2	8	7 to 10	2	4.7	positive	positive	72		10	2.0581	negative
ERS1796501	08_003-1	ERR2014376	3	MGYA00132148	08_003_a	14-05-22	08-003	24	1	8	7 to 10	4	5	positive	positive	63.64	no	14	2.0537	positive
ERS1796502	08_003-2	ERR2014377	3	MGYA00132179	08_003_b	14-06-26	08-003	24	2	0	0 to 3	0	4.5	negative	negative	0		7	0.9971	positive
ERS1796503	08_006-1	ERR2014378	3	MGYA00132166	08_006_a	14-08-27	08-006	23	1	8	7 to 10	4	5.5	positive	positive	76	no	13	2.1163	positive
ERS1796504	08_006-2	ERR2014379	3	MGYA00132156	08_006_b	14-09-22	08-006	23	2	0	0 to 3	0	4.5	negative	negative	0		11	0.2482	positive
ERS1796505	08_006-3	ERR2014380	3	MGYA00132172	08_006_c	14-10-01	08-006	23	3	0	0 to 3	0	4.5	negative	negative	0		8	0.6006	na
ERS1796506	08_006-4	ERR2014381	3	MGYA00132150	08_006_d	14-10-21	08-006	23	4	0	0 to 3	0	4.5	negative	negative	0		8	0.8079	na
ERS1796507	08_006-5	ERR2014382	3	MGYA00132181	08_006_e	14-11-27	08-006	23	5	no Nugent Score	na	0	na	negative	negative	0		10	0.2177	na
ERS1796508	13_019-1	ERR2014383	3	MGYA00132163	13_019_a	15-01-14	13-019	26	1	8	7 to 10	4	6.1	positive	positive	100	no	11	2.0857	positive
ERS1796509	13_019-2	ERR2014384	3	MGYA00132153	13_019_b	15-02-05	13-019	26	2	0	0 to 3	0	3.6	negative	negative	0		3	0.1077	positive
ERS1796510	13_019-3	ERR2014385	3	MGYA00132174	13_019_c	15-02-12	13-019	26	3	0	0 to 3	0	4.1	negative	negative	0		2	0.0373	na
ERS1796511	13_019-4	ERR2014386	3	MGYA00132186	13_019_d	15-03-03	13-019	26	4	0	0 to 3	0	4.4	negative	negative	0		3	0.0697	na
ERS1796512	13_019-5	ERR2014387	3	MGYA00132151	13_019_e	15-05-28	13-019	26	5	no Nugent Score	na	0	na	negative	negative	0		2	0.0373	na
ERS1796513	13_022-1	ERR2014388	3	MGYA00132173	13_022_a	15-02-17	13-022	37	1	10	7 to 10	4	6.1	positive	positive	53.7	no	12	2.0271	positive
ERS1796514	13_022-2	ERR2014389	3	MGYA00132164	13_022_b	15-03-16	13-022	37	2	0	0 to 3	0	3.6	negative	negative	0		4	0.0713	positive
ERS1796515	15_006-1	ERR2014390	3	MGYA00132157	15_006_a	14-08-26	15-006	24	1	8	7 to 10	4	6.1	positive	positive	78.57	no	11	1.9081	negative
ERS1796516	15_006-2	ERR2014391	3	MGYA00132165	15_006_b	14-09-05	15-006	24	2	8	7 to 10	4	6.1	positive	positive	20		11	1.9038	negative
ERS1796517	17_004-1	ERR2014392	3	MGYA00132160	17_004_a	15-05-20	17-004	48	1	10	7 to 10	4	5.5	positive	positive	40.74	no	13	2.2727	negative
ERS1796518	17_004-2	ERR2014393	3	MGYA00132149	17_004_b	15-06-03	17-004	48	2	8	7 to 10	4	6	positive	positive	94		13	2.0456	negative
